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Abstract
The identification of chromosomal rearrangements is of utmost importance for the diagnosis and 
classification of specific leukaemia subtypes and therefore has an impact on therapy choices in individual 
cases. The t(7;12)(q36;p13) is a cryptic rearrangement that is difficult to recognise using conventional 
cytogenetic methods and is often undetected by reverse transcription polymerase chain reaction due to 
the absence of a fusion transcript in many cases. Here we present a reliable and easy to use dual colour 
fluorescence in situ hybridisation assay for the detection of the t(7;12)(q36;p13) rearrangement. A comparison 
with previous similar work is given and advantages and limitations of this novel approach are discussed.
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Introduction
Chromosomal translocations are a hallmark of cancer and 
leukaemia and are useful biomarkers for disease diagnosis 
and follow up [1]. The t(7;12)(q36;p13) rearrangement is a rare 
chromosomal translocation recurrently found in a subset of 
paediatric leukaemia affecting mostly children between 0-2 
years, also known as infant leukaemia [2-5]. It has been estimated 
that this cytogenetic abnormality occurs in approximately 
one third of infant leukaemia, representing the second most 
common rearrangement after those involving the MLL gene 
on 11q23 [2,6]. Conventional cytogenetic methods of chro-
mosome banding are broadly used in diagnostic laboratories. 
However, these have limitations when analysing complex or 
cryptic abnormalities. Because the t(7;12)(q36;p13) affects the 
terminal regions of 7q and 12p respectively, the rearrangement 
is difficult to identify by conventional karyotyping. Nowadays, 
various other techniques are in place for the detection of chro-
mosomal translocations. One of these is reverse transcription 
polymerase chain reaction (RT-PCR) that uses primers specific 
for known translocations, identifiable when a fusion transcript 
is present [7]. This approach is commonly used in diagnostic 
laboratories as it allows for a quick detection of the abnormali-
ties. A fusion transcript arising from the t(7;12) rearrangement 
has been described as the HLXB9-ETV6 fusion [8]. However, 
this fusion transcript has been identified in only approximately 
50% of cases harbouring the t(7;12)(q36;p13) [6,9]. Therefore, 
a more reliable method must be used for the detection of this 
rearrangement. Fluorescence in situ hybridisation (FISH) is cur-
rently applied in many diagnostic laboratories using in-house 
made probes, custom made probes or commercially available 
probes. An advantage of using FISH is the possibility of con-
ducting single cell analysis on both metaphase chromosomes 
and interphase nuclei, allowing the possibility to estimate the 
proportion of cells carrying the abnormality. Here we report 
the use of a novel dual colour FISH assay for the identification 
of the t(7;12)(q36;p13) rearrangement in paediatric leukae-
mia. This has been designed as an alternative to a previously 
described three colour probe set [10]. 
Findings
Patient samples
Archival methanol: acetic acid fixed chromosomes and cells 
suspensions from four patients previously described were 
used in this study [2,10-12]. All of the patients were children 
affected by myeloid disorders (see Table 1). The samples were 
selected on the basis of harbouring a t(7;12) rearrangement 
previously characterised using FISH assays different from the 
one here reported. 
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pt Diagnosis Previous FISH 
probes
Reference Comparison with previous 
FISH studies
1 T-ALL 
later revised as AML
49,XX,+6,t(7;12)(q36;p13),+8,+19[3]/ 
50,idem,+18[7]
YAC 964c10 (12p13)
Vysis TEL/AML1
ETV6 exon specific 
cosmids
YAC HSC7E551
(7q35)
YAC HSC7E526
(7q36)
pt. 4 in [2] Refined chromosome 7 
breakpoint
2 AML-M4 48,XY, t(7;12)(q36;p13),+8,+19 YAC 964c10 (12p13)
ETV6 exon specific 
cosmids
PAC H_DJ1121A15 
(7q36)
Cos 121b1 (7q36)
Cos 227e6 (7q36)
Cos 85c10 (7q36) 
Cos 133f02 (7q36)
pt 6 in [2] Confirmed previous  
findings
pt 4 in [12]
3 AML-M0 47,XY,t(7;12)(q36,p13),+der(19) YAC 964c10 (12p13)
ETV6 exon specific 
cosmids
PAC H_DJ1121A15 
(7q36)
Cos 121b1 (7q36)
Cos 227e6 (7q36)
pt 5 in [2] Confirmed previous  
findings
Cos 107a07 (7q36)
Cos 148a04 (7q36)
Cos 85c10 (7q36)
Cos 133f02 (7q36)
pt 3 in [12]
Three colour FISH 
probe
Pt 2 in [10]
4 MDS 46,XX,der(7)t(7;12)(q22;p13)del(7)
(q22q36)
YAC 964c10 (12p13)
ETV6 exon specific 
cosmids
pt 1 in [2] Confirmed previous  
findings
Various 7q22and 
7q36 probes
Three colour FISH 
probe
pt 1 in [12]
pt 1 in [10]
Table 1. Clinical features, cytogenetic data and FISH findings relative to the patients analysed in this study.
Fluorescence in situ hybridization (FISH) 
A dual colour FISH probe set for the detection of the t(7;12)
(q36;p13) was provided by MetaSystems (MetaSystems GmbH, 
Altlussheim, Germany). A schematic representation of the 
probes and their location along chromosomes 7 and 12 is 
shown in Figure 1. FISH experiments were carried out accord-
ing to the manufacturer’s instructions with slight modifica-
tions. Briefly: slides were denatured with 70% formamide at 
72°C for 3 min. Probe mixture was denatured at 72°C for 8 
min, incubated at 37°C for 30 min, and subsequently applied 
to the slides under a 22×22 mm cover-slip. After overnight 
hybridization, slides were washed with 2×SSC (pH 7.0) for 5 
min on shaker, then transferred to 0.4×SSC (pH 7.0) at 70°C  
for 5 min followed by another wash in 2×SSC/Tween20 for 
5 min on shaker and then a final wash in 1×PBS for 5 min 
on shaker. The slides were then mounted in Vectashield 
(Vector Laboratories Ltd., Peterborough, UK) containing 49, 
6-Diamidine-29-phenylindole dihydrochloride (DAPI). Hybrid-
ized chromosomes and nuclei were viewed and images were 
captured using an Olympus BX41 fluorescence microscope and 
SmartCapture 3 software (Digital Scientific, Cambridge, UK).
Results and discussion
The dual colour FISH approach enabled us to detect the 
t(7;12) rearrangement in all four cases analysed. In three 
of the patient samples (patient nos. 1-3), it was possible to 
visualise the fusion hybridisation signals on both der(7) and 
der(12), as this translocation is reciprocal. However, in one of 
the patients (no. 4), the translocation was accompanied by 
a deletion of the chromosome 7 region comprised between 
bands q22 and q36, in the same homolog affected by the 
translocation. A precise mapping of the deletion and trans-
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location breakpoints enabled us to determine, in a previous 
study, that the chromosome 7 fragment translocated onto 
the der(12) included a small region from 7q22 joint with 7q36, 
indicating that the deletion event might have been prior to 
the translocation event [12]. In this case, only one fusion signal, 
on the der(12), was visible on both metaphase chromosomes 
and interphase nuclei, due to the fact that the chromosome 
7 breakpoint occurred outside of the region covered by 
the probe. FISH images of metaphase chromosomes and 
interphase nuclei are shown in Figure 2. All of the samples 
used in this study had been previously analysed by FISH us-
ing various probe sets [2,10-12]. These are listed in Table 1. 
Two of the patients were previously studied using the three 
colour probe set (patient nos. 3 and 4) [10] and have been 
re-analysed here using this novel approach. The findings here 
reported confirmed analyses previously performed in most 
cases (patient nos 2-4) and refined the abnormality in one 
case (patient no. 1), where the chromosome 7 breakpoint was 
previously mapped between 7q35 and 7q36 and has now been 
narrowed down to between the regions flanking HLXB9. The 
dual colour FISH assay has the advantage over the three colour 
Figure 1. Map of probes. 
Probes for the dual colour break-apart FISH assay were designed to 
flank the HLXB9 gene (in red) on chromosome 7 and the ETV6 gene 
(in green) on chromosome 12. Due to the probes design, a gap is left in 
the genomic region that includes HLXB9 on 7q36 and ETV6 on 12p13. 
This may result in the visualisation of double signals (doublets) on the 
non-translocated chromosomes in the interphase nuclei (see FISH 
images in Figure 2).
Figure 2. Fluorescence in situ hybridisation shows t(7;12) rearrangement.
The ideograms on the left show possible patterns of hybridisation using the dual colour break-apart probe (A and G). 
A straight forward t(7;12)(q36;p13) translocation results in the juxtaposition of green and red signals on the der(7) 
and the der(12), whereas the normal chromosome 7 carries only red signals and the normal chromosome 12 carries 
only green signals (A). This is visible on the metaphase chromosomes (B).  In the nuclei it is possible to visualise one 
green signal and one red signal as well as two red-green signals (C-E). By the analysis of interphase FISH alone, it is 
not possible to discriminate between the two derivatives, although it is assumed that one would be a der(7) and the 
other one would be a der(12) (F) Images B-E were obtained using patient no. 3 sample. A different hybridisation 
pattern is shown on the sample from patient no. 4, where the der(7) involved in the translocation is also affected by a 
deletion. This results in a shorter chromosome 7 carrying only green signals and a der(12) carrying green-red signals, 
whereas the normal chromosomes 7 and 12 carry red only and green only signals respectively (G and H). In the 
interphase nuclei it is possible to identify confidently the der(12) as a green-red signal in this case, whereas the normal 
chromosome 7 is identified by red signals alone. Green signals may indicate the normal chromosome 12 or the der(7), 
although it is noted that in most nuclei one of the two green signals is smaller, indicating the der(7) (I-J). 
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one of relying on a fluorescence microscope equipped with 
the most commonly used filter sets. These recognise the red 
and green fluorochromes used to label the probes and the 
DAPI counterstaining. However, it has to be noted that the 
two derivatives cannot be distinguished based on the FISH 
pattern alone as they both carry a red-green fusion signal. 
Therefore, although the derivatives can be discriminated on 
the metaphases based on chromosome morphology, this is 
not possible when analysing interphase nuclei. Furthermore, 
a double fusion signal will be visualised only in cases of true 
reciprocal translocations without associated deletions. In the 
presence of deletion involving either of the chromosome 7 
or 12 regions covered by the probes, or where one of the 
translocation breakpoints falls outside of the region covered 
by the probe, one fusion signal might be replaced by a single 
colour signal such as in case no. 4 here presented. In deletion 
cases, particular attention should be given to chromosome 
morphology as a large deletion might impact on the iden-
tification of the derivative. The dual colour FISH assay here 
presented has been designed to cover the regions flanking 
the HLXB9 gene, to allow detection of the most common 
t(7;12) rearrangements. However, a certain heterogeneity in 
the chromosome 7 breakpoints has been described in the 
t(7;12) rearrangements [12], therefore situations in which 
one of the fusion signals is not visualised are likely to occur.
Conclusion
The availability of a dual colour FISH assay specific for the 
t(7;12)(q36;p13) will enable diagnostic laboratories to identify 
easily and confidently this cryptic chromosomal abnormality. 
The correct identification of this rearrangement will also help 
estimating its real incidence in infant leukaemia.
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